October 26, 2016 10:16 AM ET


Company Overview of Envoy Therapeutics, Inc.

Key Executives for Envoy Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Brad A. Margus 48 RelationshipsCo-Founder, Chief Executive Officer and Director55
Jeffrey Friedman M.D., Ph.D.15 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Paul Greengard Ph.D.83 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Nathanial Heintz Ph.D.No RelationshipsCo-Founder--
Nobel Laureate No RelationshipsFounder--
View More Key Executives

Envoy Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
John D. Diekman Ph.D. 139 Relationships5AM Venture Management LLC73
Brad A. Margus 48 RelationshipsEnvoy Therapeutics, Inc.55
Jeffrey Friedman M.D., Ph.D. 15 RelationshipsEnvoy Therapeutics, Inc.--
Paul Greengard Ph.D. 83 RelationshipsIntra-Cellular Therapies, Inc.--
William Warren Bradley 200 Relationships5AM Venture Management LLC73
View All Board Members

Envoy Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Envoy Therapeutics, Inc. CEO Compensation
Industry Average


Depomed, Inc. Announces Board Changes
October 25, 2016 8:07 PM ET
Evergreen-Agra, Inc. Announces New Appointments
October 25, 2016 5:33 PM ET
SciClone Pharmaceuticals, Inc. appoints Carey Chern as General Counsel
October 25, 2016 4:24 PM ET
Atrin Pharmaceuticals, Inc. Appoints Gerhard J. Sperl as Vice President, Chemistry, Manufacturing and Controls
October 25, 2016 12:30 PM ET
Recursion Pharmaceuticals, LLC Announces John Pereira as Chief Operating Officer
October 25, 2016 11:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Envoy Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.